fig2

Cutaneous toxicities of targeted therapies in the treatment of hepatocellular carcinoma

Figure 2. Example of rash on the trunk with TKI treatment. Used with permission under the Creative Commons Attribution License. (http://creativecommons.org/licenses/by/2.0)[31]. TKI: tyrosine kinase inhibitor

Hepatoma Research
ISSN 2454-2520 (Online) 2394-5079 (Print)

Portico

All published articles are preserved here permanently:

https://www.portico.org/publishers/oae/

Portico

All published articles are preserved here permanently:

https://www.portico.org/publishers/oae/